Skip to main content
. Author manuscript; available in PMC: 2014 Oct 1.
Published in final edited form as: J Heart Lung Transplant. 2013 Aug 13;32(10):10.1016/j.healun.2013.07.004. doi: 10.1016/j.healun.2013.07.004

Table 3.

Treatment regimens administered for acute antibody mediated rejection.

Patient ATG IVIG dose (number of doses) Rituximab Plasma Exchange number of treatments Bortezomib dose (number of doses) Eculizumab Survived to discharge
1 Yes* None - Not done - - Yes
2 - 1 g/kg (1) 375 mg/m2 12 - - Yes
3 - 1 g/kg (1) 375 mg/m 2 Not done - - Yes
4 - 1 g/kg (1) 375 mg/m2 Not done - - Yes
5 - 0.5 g/kg (2) 375 mg/m2 10 - - No
6 - 0.5 g/kg (1) 375 mg/m2 Not done - - No
7 - 0.5 g/kg (1) 375 mg/m2 5 - - Yes
8 - 0.5 g/kg (2) 375 mg/m2 Not done - - Yes
9 - 1 g/kg (1) 375 mg/m2 Not done - - Yes
10 - 0.5 g/kg (2) 375 mg/m2 Not done - - Yes
11 - 0.5 g/kg (1) - 3 - - Yes
12 - 0.5 g/kg (1) 375 mg/m 2 Not done - - Yes
13 - 0.5 g/kg (1) 375 mg/m2 Not done - - Yes
14 - 1 g/kg (1) 375 mg/m2 Not done - - No
15 - 0.5 g/kg (2) - Not done - - Yes
16 - 0.5 g/kg (3) 375 mg/m2 5 - - No
17 - 0.5 g/kg (1) 375 mg/m2 Not done - - Yes
18 - 1 g/kg (2) 375 mg/m2 5 1.3 mg/m2(8) - Yes
19 - 0.5 g/kg (1) 375 mg/m2 1 1.3 mg/m2(1) - No
20 - 0.5 g/kg(1) 1 g/kg (2) 375 mg/m2 Not done - - Yes
21 - 1 g/kg (3) 375 mg/m2 5 1.3 mg/m2(4) Yes** No

ATG: antithymocyte globulin, IVIG: intravenous immune globulin

(-): Not given

*

ATG dosing: 1 mg/kg/day for 5 days

**

Eculizumab dosing: 1200 mg IV Day 1, 900 mg IV Day 8, 900 mg IV Day 15